What is Viking Therapeutics's total revenue?

Viking Therapeutics (VKTX) reported total revenue of $0 in Q1 2026.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Viking Therapeutics VKTX Total Revenue

Total Revenue at other companies

Eli LillyLLY

$19.8B+55.5%

PfizerPFE

$14.45B+5.4%

AmgenAMGN

$8.62B+5.8%

Madrigal Pharmaceuticals, Inc.MDGL

$311.34M+127%

Crinetics PharmaceuticalsCRNX

$10.73M+2,873%

Relay Therapeutics, Inc.RLAY

$3M-60.9%

Other financials

Income statement

See full

Operating income-$164.1M-196%

Net income-$158.3M-247%

EPS (diluted)-$1.37-234%

Balance sheet

See full

Cash & equivalents$118.1M+211%

Total debt$137.0K-87.8%

Total equity$501.9M-40.7%

Total assets$608.2M-29.8%

Cash flow

See full

Operating cash flow-$114.0M-118%

Valuation

See full

Market cap$3.53B+38.7%

Returns & leverage

See full

Return on equity-70%-94.5pp

Debt / equity0×0.0×

Current ratio5.7×-38.5×

Where this comes from

Reported directly by Viking Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viking Therapeutics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viking Therapeutics's total revenue?: Viking Therapeutics (VKTX) reported total revenue of $0 in Q1 2026.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.